openPR Logo
Press release

Ankylosing Spondylitis Treatment Market to Witness Growth Acceleration by 2031

05-15-2024 01:06 PM CET | Health & Medicine

Press release from: Orion Market Research

Ankylosing Spondylitis Treatment Market to Witness Growth

The global ankylosing spondylitis treatment market is projected to exhibit considerable growth during the forecast period. Ankylosing spondylitis is an inflammatory disease that leads to the fusion of some small bones of the spine (vertebrae) making the spine less flexible. The rising geriatric population is expected to be a major cause responsible for ankylosing spondylitis. The rising focus of the players operating in the ankylosing spondylitis market towards investment in R&D of drugs for its treatment along with increasing FDA approvals is expected to be the key factor contributing towards the growth of the market across the globe. AbbVie, Inc., Allergen Inc., Eli Lilly and Co., Merck & Co. Inc., Sanofi SA, Pfizer Inc., Bayer AG, Amgen Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, Endo Health Solutions, Inc., and so on are the major players operating in the global ankylosing spondylitis treatment market.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ankylosing-spondylitis-treatment-market

These market players are making a hefty investment in their R&D sector to perform drug development for the launch of new and advanced drugs for the treatment of this disorder. For instance, in October 2019, Novartis International AG, a pharmaceutical company had received approval from European Commission (EC) to perform the up-titration of Cosentyx (secukinumab) to 300 mg for patients with active ankylosing spondylitis. The approval is based on data from MEASURE 3, a three-year study that identified the efficacy and tolerability of Cosentyx in ankylosing spondylitis patients.

In August 2019, Eli Lilly and Company, an American pharmaceutical company had received the US FDA approval for Taltz (ixekizumab) injection 80 mg/mL for the treatment of adults with active ankylosing spondylitis, also known as radiographic axial spondyloarthritis (r-axSpA). Taltz (ixekizumab) injection 80 mg/mL is the third indication of the Talz which was approved for the treatment of moderate to severe plaque psoriasis in adult patients and then approved in December 2017 for the treatment of psoriatic arthritis.

In August 2019, AbbVie's Pharmaceutical, a research-based global biopharmaceutical company, had received US FDA approval for RINVOQ (upadacitinib). RINVOQ (upadacitinib) is a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis. In December 2019, RINVOQ (upadacitinib) is proved to be effective in a Phase 2/3 trial shows for the treatment of adults with active ankylosing spondylitis who failed to respond to or are not eligible for non-steroidal anti-inflammatory drugs (NSAIDs),.

Current Market Trends Covered in the Market Report.

• North America is anticipated to hold a major market share during the forecast period.
• The rising awareness among people related to the treatment of the ankylosing spondylitis.
• Partnerships, collaborations, and new product launches - key drivers of competition in the market.

Global Ankylosing Spondylitis Treatment Market Segmentation

By Drug

• Secukinumab
• Adalimumab
• Golimumab
• Infliximab
• Etanercept
• Certolizumab Pegol
• Other

A full report of Ankylosing Spondylitis Treatment Market is available at: https://www.omrglobal.com/industry-reports/ankylosing-spondylitis-treatment-market

Global Ankylosing Spondylitis Treatment Market Segmentation by region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AbbVie, lnc.
• Allergen, Inc.
• Amgen, Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb, Co.
• Cadila Healthcare, Ltd.
• Eli Lilly and Co.
• Endo Health Solutions, Inc.
• Hoffmann-La Roche, Ltd.
• Ferring B.V.
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Treatment Market to Witness Growth Acceleration by 2031 here

News-ID: 3497570 • Views:

More Releases from Orion Market Research

Modified Atmosphere Packaging Market Booming Worldwide with Latest Trend and Future Scope by 2031
Modified Atmosphere Packaging Market Booming Worldwide with Latest Trend and Fut …
Modified Atmosphere Packaging Market is projected to grow at a CAGR of around 5% during the forecast period. Modified atmosphere packaging belongs to the flexible packaging methods which are generated by altering the initial gaseous environment near the products, whereby no further control during the storage period is performed. The atmosphere dissimilarity from that of air is generated in modified atmosphere packaging, which aids in delaying the degradation of the
Metal Packaging Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Ardagh Group, Ball Corp., Crown Holdings, Inc., and Silgan Holdings Inc.
Metal Packaging Market Increasing Demand, Growth Analysis and Future Outlook by …
Global metal packaging market is anticipated to grow at a moderate CAGR of 3.3% during the forecast period (2024-2031).A major factor supporting the market growth is the growing usage of eco-friendly can metals, since most cans are made of aluminum, which is most cost-effective materials to recycle, is the major factor expected to drive market revenue growth. Almost all aluminum used in cans can be melted down and reused. Aluminum cans can
Insecticides Market Outlook 2031: Presents Market Insights & Depth Analysis
Insecticides Market Outlook 2031: Presents Market Insights & Depth Analysis
The global Insecticide Market is anticipated to grow at a CAGR of 5.62% during the forecast period (2024-2031). Insecticide is a chemical substance used in agriculture to control and eliminate insect pests, safeguarding crops from damage and ensuring optimal yield and quality in a farming environment. The global insecticide market grows due to rising population demands and shrinking agricultural land. Insecticides protect crops, ensuring higher yields amid land scarcity. Climate change-induced pest
Indoor Farming Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | Argus Control Systems Ltd., Certhon Build B.V., Richel Group, Bowery Farming Inc., and New AeroFarms, Inc.
Indoor Farming Market is Likely to Increase at a Significantly High CAGR during …
Indoor farming market is anticipated to grow at a significant CAGR of 10.2% during the forecast period (2024-2031). The market growth is attributed to rising concerns over water levels, and land scarcity globally, requiring the adoption of innovative techniques such as vertical and indoor farming, consuming less water and land for farming. For instance, in July 2022, Bustanica opened the world's largest hydroponic farm, with an investment of $40.0 million. The

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen
Ankylosing Spondylitis Treatment Market Research and Forecast 2020-2026
The global ankylosing spondylitis treatment market is projected to exhibit considerable growth during the forecast period (2020-2026). Ankylosing spondylitis is an inflammatory disease that leads to the fusion of some small bones of the spine (vertebrae) making the spine less flexible. The rising geriatric population is expected to be a major cause responsible for ankylosing spondylitis. The rising focus of the players operating in the ankylosing spondylitis market towards investment
Ankylosing Spondylitis Market Shares, Strategies and Forecast Worldwide, 2017 - …
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it
Ankylosing Spondylitis Treatment Market Pegged for Robust Expansion During 2015 …
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture.
Ankylosing Spondylitis Market : New Study Offers Insights for 2025
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it